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Tissue cuhure-adapted cytotoxic T  cell lines and clones often do not maintain 
their  original  recognition  specificity and  function.  For  example,  many  T  cell 
lines that acquired broad specificity spectra, in some cases resembling NK activity 
have been described (1-3).  In contrast,  our group has observed that  long-term 
cytotoxic clones, after having  lost their  original  antigen  specificity, frequently 
acquire a new but equally specific cytotoxic activity for the DBA/2 mastocytoma 
tumor  cell  line,  P815  (4).  This  activity  is  distinct  from  the  NK  or  "NK-like" 
activity of other long term T  cell lines by its exclusive specificity for P815 targets 
and by the sensitivity of the cytotoxicity to inhibition  with anti-Lyt-2 antibody. 
We have therefore termed this function aged killer (AK) 1 activity (4). Because of 
their stability, independence of restimulation  with antigen,  and generally good 
adaptation  to tissue culture,  AK  cells have obvious advantages over bona fide 
cytotoxic T  cell lines for experimental purposes.  In addition, several properties 
of their cytotoxic function resemble that of bona fide cytotoxic T  cells (4).  We 
therefore evaluated the possibility of using AK cells for the study of the cytotoxic 
function of T  lymphocytes. In particular,  we investigated whether or not the T 
cell  receptor  and/or  Lyt-2 are  involved  in  AK  cytotoxicity. To  this  end,  we 
generated a series of functionally deficient variants from the prototype AK cell 
clone 96 (CI 96). A  characterization  of this collection of functional  variants for 
the  expression  of the  T  cell  antigen  receptor  and  of  Lyt-2  reveals  a  clear 
correlation of both with AK activity: Loss or low levels of Lyt-2 results in loss of 
specific  cytotoxicity for  P815  but  is  compatible  with  maintenance  of lectin- 
mediated cytotoxic function;  loss or low levels of the T  cell receptor results in 
loss of all cytotoxic activity. The  data are compatible with the notion  that  the 
antigen receptor of AK ceils has a low affinity for P815, which needs stabilization 
either by Lyt-2 or by a  lectin. We conclude that the recognition process of AK 
T  cells is similar to that of bona fide cytotoxic T  cells. 
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Materials  and  Methods 
Cell Lines and Culture Conditions.  C196 cells, originally obtained from Dr. P. Krammer, 
Deutsches Krebsforschmigs Zentrum,  Heidelberg, and all other cell lines were cultured 
in RPMI  1640 medium supplemented  with  10%  FCS,  10  -~ M  2-ME,  2.5 mM  Hepes,  2 
mM glutamine,  kanamycine (100 pg/ml), and tyrosine (10 ttg/ml) in  5%  COJair.  IL-2- 
dependent  cells were grown in the presence of 10%  rat spleen  cell Con A  supernatant 
(ConASN) as a source of IL-2 and 10 mg/ml a-methyl-mannoside (aMM). IL-2-independ- 
ent  cell  lines  were  grown  in  the  absence  of  IL-2  and  aMM.  In  some  experiments 
recombinant human IL-2 (rec. IL-2; Sandoz Forschungsinstitut,  Wien, Austria) was used, 
as indicated, adjusted to 100 U/ml (1  U  -- 100 pg rIL-2). 
Antibodies and  Antisera.  Rabbit  anti-mouse  T  cell  antigen  receptor  antiserum  was 
produced by immunizing rabbits with immunoprecipitated T  cell receptor material using 
a  clonotypic  antibody  and  the  OVA-specific  T  cell  hybridoma  DOll.10  (R.  Kubo, 
Manuscript in preparation).  It was shown to react with most normal T  cells and T  cell 
tumors and  to immunoprecipitate  T  cell  receptor.  Also used  were anti-Thy-l.2  (Code 
585, Olac), anti-L3T4(GK  1.5) anti-Lyt-2 (56-6.7) (5).  Anti-H-2 class I antibody 9C5 was 
obtained by fusion of spleen  cells of AKR mice repeatedly immunized with CI 96 cells, 
with  X63.Ag8.653 cells.  Antibody 9C5  precipitates  class I  MHC molecules from C1 96 
and  from other  cells  (unpublished  observation).  Strain  distribution  is  similar  to public 
specificity H27. 
Cytotoxic Assay.  Cells were assayed in a 4 h 5~Cr release assay at various E/T cell ratios. 
Effector cells in 0.1 ml of culture medium (see above) were added to 2 ×  1035~Cr-labeled 
P815  cells.  For lectin  facilitated  cytotoxicity, PHA (Gibco Laboratories,  Grand  Island, 
NY; 670/0576,  1% of stock solution) was added to the test mixture. After incubation for 
4 h at 37°C the plates were centrifuged at  1,000 rpm for 10 min and 0.1  ml supernatant 
was removed for counting. Percent specific lysis was calculated as 100 ×  (experimental - 
low  control)/(acid  lysis  -  low  control).  Each  effector  cell  concentration  was  tested  in 
triplicate. 
Cytofluorometric Analysis.  Cytofluorometric  analyses  were  made  using  a  50  H  cell 
sorting device (Ortho Diagnostic Systems,  Inc.,  Raritan,  NJ).  FITC-labeled F(ab)~  anti- 
MIg and  F(ab)2  anti-rat  Ig were purchased  from Medac,  Hamburg,  FRG.  Incubations 
with first and second antibodies were for 30 min on ice, and were followed by 3 washes. 
Radiolabeling of Cells.  Cell surface proteins were labeled by lactoperoxidase-catalysed 
iodination  using  a  modification  of the  metbod  described  by  Hubbard  and  Cohn  (6). 
Briefly, 50 ×  10 6 cells were suspended in 1 ml PBS and 250 ttl of Enzymobead  TM reagent 
(Bio-Rad Laboratories, Miinchen,  FRG) and  1.5 mCi of IzsI (Amersham Corp., London) 
were added. The iodination was carried out by adding, eight times,  50 ttl of 13-D-glucose 
(Sigma Chemical Co., Taufkirchen, FRG) in two minute intervals.  After the last addition 
of/3-D-glucose, the reaction was allowed to proceed for an additional 30 min and stopped 
by adding a large volume of ice-cold PBS containing 5 mM KI. Labeled cells were further 
washed five times with  PBS containing  10 mM  iodoacetamide and then  treated  for 45 
min on ice with lysis buffer (50 mM Tris-HCl, pH 8.0; 0.15 M  NaCI; 1%  NP-40;  1 mM 
EDTA,  2  mM  PMSF;  10  mM  iodoacetamide;  and  0.02%  NAN3).  Cell  lysates  were 
centrifuged for 15 rain in an airfuge (Beckman Instruments Inc., Fullerton, CA) at I 0,000 
g. Supernatants were stored at -70°C. 
Two-dimensional Gel Electrophoresis.  Two-dimensional (nonreduced/reduced)  polyac- 
rylamide gel electrophoresis employed the protocol described by Goding and Harris (7). 
The first dimension consisted of a 7.5% acrylamide tube gel. Sample volumes were 50 #1 
and contained  10 ttl of labeled cell supernatant (corresponding to ~ 1.5 ×  106 cells).  Gels 
were run at  1 mA per tube constant current for 3 h. When the bromphenol blue marker 
reached the  bottom,  the  gel was removed and equilibrated  for  1 b  at  25°C  in  sample 
buffer with 5%  2-ME and 50 mM  DTT.  The second dimension was performed using a 
10% acrylamide slab gel. Gels were fixed, stained, and destained.  Molecular weights were 
determined  by  reference  to  the  mobility  of low  molecular  weight  standard  proteins 
(Pharmacia Fine Chemicals, Freiburg, FRG) applied on tbe same gel. Autoradiographs of JANKOVI(~  ET  AL.  1461 
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FmURE  1.  Limiting dilution cloning of CI 96 cells at 0.3 cel|s/microwe|l  in  ]5% ConASN. 
Wells with growing cells (I08/480, cloning efficiency =  0.86) were tested in 5tCr release assay 
for cytotoxicity  against P815 cells in the absence and presence of 2% PHA. Each dot represents 
the result on one culture well. 
the dried gels were visualized using intensifying screens (Dr. Go•s, Heidelberg, FRG) and 
X-R5 films (Eastman Kodak Co., Stuttgart,  FRG) at -70°C. 
lmmunoprecipitation.  Aliquots of cell lysate supernatant,  precleared with packed pro- 
tein  A-Sepharose  beads (Pharmacia  Fine Chemicals),  were mixed with either  50 t~l of 
rabbit anti-mouse  T  cell antigen  receptor serum or with  50 ~1 of normal  nonimmune 
rabbit serum. Two h later, 50 ~1 of protein A beads were added and after an overnight 
incubation at 4°C they were thoroughly washed with lysis buffer. The specifically bound 
material  was removed by boiling in sample buffer and subjected to two-dimensional gel 
electrophoresis. 
Results 
General Characteristics of  Cl 96.  Most functional properties of CI 96 have been 
described before (4). Generated in  1980, the cells were grown in IL-2-containing 
media  for  several  years  before  their  cytotoxic  activity  for  P815  targets  was 
discovered  fortuitously.  Assays  for  P815  cytotoxicity  performed  early  in  its 
development  had  been  negative  (8),  suggesting  that  the  cell  line  had  switched 
from its original,  unknown  specificity to AK activity.  Cytotoxicity for P815 can 
be shown in a specific 4 h, 51Cr release assay, as well as in the presence of a lectin 
such  as  PHA  and  results  in  target  cell  death  (unpublished  observations).  Not 
only  the  specific  P815  kill,  but  also  the  lectin-facilitated  cytotoxic  activity  is 
largely restricted  to P815 targets (Woodland  et al., manuscript  in preparation). 
Specific cytotoxic activity, but not lectin-facilitated  cytotoxicity, is readily inhib- 
ited by anti-Lyt-2 antibody (4). 
Selection of Noncytotoxic Variants.  A  first set of functional  variants  of CI  96 
was selected in cloning experiments  for loss of all cytotoxic activity. Fig.  1 shows 1462  T  CELL  RECEPTOR  AND  LYT-2  ON  AGED  KILLER  CELLS 
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FIGURE 2.  5~Cr  release assay of CI 96 cells and of five noncytotoxic variants in the absence 
(O) and presence (O) of 2% PHA against P815 target cells. Variants 138 and 125 were obtained 
from the first, and variants 4H7,  10A4,  and  2F6  were obtained from the second cloning 
experiment. E/T ratios are twofold dilution steps. 
results from assaying 108 subclones growing in microwells originally seeded with 
0.3  C1  96  cells/well  (88%  clonality).  Cytotoxic  activities  for  P815  with  and 
without PHA were measured at a single unknown cell concentration,  and were 
found to be highly correlated.  Clones with <10%  specific 51Cr release in both 
assays were grown up and  retested in a  similar experiment  (data not shown).  3 
out of 14 clones from  this  experiment,  and  4  out  of 10  clones from another 
experiment, remained essentially negative for all cytotoxic activity upon repeated 
assays over a period of more than  1 yr. Five of these seven clones were studied 
in this paper, and representative 5~Cr release assays are given in Fig. 2. 
Selection oflL-2-independent Variants.  In a routine assay for IL-2 dependence 
of the  growth of various T  cell lines,  we found that  the noncytotoxic variants 
described above grew essentially  independent  of exogenously added  IL-2  (see 
Fig.  4), even though  these cells had been derived and subsequently cultured in 
the presence of ConASN. We suspected a correlation between IL-2-independent 
growth and  loss of cytotoxic function and  performed experiments in which CI 
96  cells were selected  for  growth  in  the  absence  of exogenous  IL-2.  Various 
dilutions of cells were cultured in medium without added IL-2 in  l  ml cultures, 
24  per  cell  concentration.  Analysis  of the  growing  cultures  according  to  the 
Poisson distribution (9) suggested that about 1/400 Ci 96 cells grew under these 
conditions (Fig.  3), whereas the plating efficiency of CI 96 cells in the presence 
of IL-2 is close to 1/1  (see Fig.  1). Among a series of IL-2-independent cell lines 
thus obtained, we present here data on 2 lines, and on 3 clones derived from a 
third  line.  The  lines  (96  MedA and  96  MedC)  were grown  from  300  CI  96 
cells/well. The  clones (96  E7,  96 G12,  and  96  El2)  were derived from a  line 
originally  grown  from  2  X  10 4  CI  96  cells/well.  This  line  was cloned  at  0.3 
cells/well in the presence of ConASN, because its plating efficiency in the absence 
of  IL-2  was  unsatisfactory  for  effective  cloning.  Culture  of the  clones  thus 
obtained was continued in medium without IL-2. 
IL-2-independent  Growth of Variants of Cl 96.  As mentioned  above, variants 10- 
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FIGURE 3.  Limiting dilution analysis of CI 96 cells that grow in the absence of ConASN. 24 
2-ml culture wells were set up for each cell concentration. Growth was recorded by  visual 
examination twice weekly and the results given are from day 14. Frequencies were determined 
according to Taswell (9) and varied between 1/300 and 1/4000 in several experiments. Most 
but not all cultures that initially grew could be developed into continuous lines. 
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FIGURE 4.  Growth curves of Cl  96  cells and  of several  variants  in  the  presence (O) and 
absence (O) of 100 U recombinant human IL-2. Cells were seeded at 104/ml in 2 ml cultures 
on day 0, and viable cells were counted by trypan blue exclusion daily.  10A4 is a noncytotoxic 
variant and its growth behaviour is representative for all other noncytotoxic variants studied 
(see Fig.  2). 96MedA,  96MedC, and 96G12 are IL-2-independent variants and their growth 
behavior  is  representative  for  that  of  the  other  IL-2-independent  variants  (see  Fig.  5). 
Generation times varied between ~7.5 h (10A4) and 14 h (C1 96). 
selected  for  loss of cytotoxic  function  turned  out  to be  IL-2-independent,  with 
respect to growth.  Since all additional  variants  were selected  for IL-2  independ- 
ence  we  should  expect  all  variants  described  above  to  grow  in  the  absence  of 
exogenously  added  IL-2.  Fig.  4  shows  that  growth  curves  of  representative 
variants  are  essentially  identical  in  the  absence  and  presence  of  100  units  of 
recombinant  human  IL-2 (rIL-2).  All other variants described  in this paper have 
growth  properties  similar to those shown  in  Fig.  4.  Thus,  IL-2 does not seem  to 
have  any  influence  on  the growth  of these  variant  cells,  whereas  C1  96  cells are 
essentially  dependent  on  IL-2.  No  difference  was observed  between  cells grown 
in  rIL-2  and  in  ConASN  (data  not  shown).  None  of the  IL-2-independent  cell 1464  T  CELL  RECEPTOR  AND  LYT-2  ON  AGED  KILLER  CELLS 
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FIGURE 5.  Cytotoxic activities of lL-2-independent variants that have been grown in  the 
absence (top) and for 2 d in the presence (bottom) of 100  U of recombinant human IL-2. 5~Cr 
release assay was performed in the absence (O) and presence (O) of 2% PHA on P815 target 
cells. E/T ratios are threefold dilution steps. 
lines constitutively secretes detectable concentrations  of IL-2 or IFN-3, into  its 
supernatant,  as determined in standard assays (data not shown). 
Cytotoxic Function of IL-2-independent  Variants of Cl 96.  Functionally,  Cl  96 
variants  selected  for  IL-2-independent  growth  fall  into  four  types.  Type  I  is 
represented  by 96  MedA,  and  the  results  of its analysis (Fig.  5) show that  all 
functional properties of CI 96 are maintained,  i.e., cytotoxic activity for P815 in 
the absence and presence of PHA. The reduced cytotoxic activity of 96MedA as 
compared with C1  96 (compare  Fig.  2) is the result of a  diminished activity of 
each individual cell and not of contamination  with noncytotoxic cells, as shown 
by limiting dilution analysis (data not shown). Culture of 96 MedA cells for 2 d 
in the presence of rIL-2 or ConASN induces only a small enhancement of their 
cytotoxicity. 
Type II is represented by two cell lines, 96MedC and 96E7. These cells, when 
cultured  without  IL-2,  retain  PHA-facilitated  cytotoxicity  for  P815  but  are 
inactive in a specific assay (Fig. 5). When cultured for 2 d or more in the presence 
of rIL-2, or ConASN, specific cytotoxicity for P815 returns. This IL-2-inducible 
cytotoxic activity is clearly weaker than  in CI 96 and was unstable in all type II 
variants  obtained  to  date.  After  culture  periods  of several  weeks  to  several 
months,  type II  variants  gradually  lose inducibility by IL-2 and  turn  into type 
lII variants,  which are represented by 96G12 in Fig. 5. These cells are capable 
of lectin-facilitated,  but not of specific P815 kill, independent  of whether they 
are cultured  in  the presence  or absence of IL-2.  Type III  represents  a  stable 
phenotype over many months of culture. (~)  CL 96 
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FIGURE 6.  Cytofluorograms of CI 96 cells (A) and of non-cytotoxic  variant 2F6 (B), both 
cultured in presence of ConASN, using monoclonal rat anti-Lyt-2  (56-6.7) and monoclonal 
mouse anti-H-2 class I (9C5) antibodies•  Panels marked control are FITC labeled goat anti- 
mouse Ig(Fab~) and FITC labeled goat anti-rat Ig (Fab2) used as second antibodies.  Numbers 
in each panel give the percent of cells that appear within region I. The fluorescence  intensity 
is plotted in logarithmic  scale• All other noncytotoxic variants (see Fig. 2) have the same Lyt- 
2- phenotype as 2F6. 
Variant  96E12  had negligible  cytotoxic activity in both assays (Fig.  5).  These 
cells  are  therefore  referred  to  as  type  IV,  together  with  the  cells  originally 
selected as noncytotoxic variants• 
Lyt-2  Expression of Cl  96  Variants•  Routine  typing  of  cell  lines  by  flow 
cytofluorometry showed that C1 96, as well as all  variants,  express Thy-l.2  and 
are  negative  for  L3T4  (data  not shown).  Typing  for  Lyt-2,  however,  revealed 
significant  differences  between  different  cell  lines.  Fig.  6  and  7  show  cytofluo- 
rograms  of the  staining  of various  cell  lines  with  monocional  rat  anti-Lyt-2 
FIGURE 7.  Cytofluorograms of IL-2-independent variants cultured without IL-2 (-IL-2) and 
cultured for 2 d in the presence of 100 U of recombinant human IL-2 (+IL-2).  Antibodies 
are the same as in Fig. 6.96MedC (A) and 96E7 (B) are type II variants whose specific cytotoxic 
activity and Lyt-2 expression  is induced by culture in IL-2.96MedA (C) has specific cytotoxic 
activity, and 96G12 (D) lacks specific cytotoxic activity both in the presence and absence of 
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antibody (56-6.7) and with monoclonal mouse anti-MHC class I antibody (9C5) 
for control.  All cell lines stain  with similar  intensity with this control antibody, 
which appears to detect class I epitopes similar in distribution to public specificity 
H27  (unpublished  observations).  In  contrast,  Lyt-2 expression  varies  between 
different cell lines and clearly correlates with cytotoxic activity: Fig. 6 compares 
C1  96  (Lyt-2  ÷)  with  the  noncytotoxic  variant  2F6,  which  is,  like  all  other 
noncytotoxic variants, Lyt-2 negative. Fig. 7 A and B show the striking behaviour 
of type II variants that are low or negative for Lyt-2 when cultured without IL- 
2, and increase their Lyt-2 expression when cultured with IL-2. This induction 
of Lyt-2 by IL-2 is more clearly seen with 96MedC but also apparent  in 96E7. 
The increase in Lyt-2 expression is selective because MHC class I expression is 
not significantly  enhanced  by culture  in  IL-2.  Fig.  7C and D  show that  Lyt-2 
expression  of type  I  and  type  III  variants  is  not  altered  by culture  in  IL-2; 
96MedA is high, whereas 96G12 is low, under both culture conditions. 
These results strongly suggest that  Lyt-2 is involved in the specific cytotoxic 
activity of C!  96  cells;  lack  or  low expression  of Lyt-2 is accompanied  by the 
inability  to  kill  P815  in  a  specific  assay  but  does  not  seem  to  affect  lectin- 
facilitated cytotoxicity. Reinduction of Lyt-2 by IL-2 is accompanied by return 
of specific cytotoxicity but leaves iectin-facilitated activity largely unaffected. 
Expression  of the T cell Antigen Receptor on Cl 96 Variants.  The mouse T  cell 
antigen  receptor is a  disulfide-linked heterodimer of two polypeptide chains,  0~ 
and/3, each of an approximate molecular mass of 40-45 kD (10-13). Due to the 
fact  that  very  few cell  surface  proteins  of mouse  T  cells  are  disulfide-linked 
heterodimers,  the T  cell receptor can be identified by running a  total lysate of 
125I  surface-labeled T  cells by 2-dimensional  SDS-gel electrophoresis in  which 
the first dimension is run under nonreducing conditions and the second dimen- 
sion is run under reducing conditions (7). The T  cell receptor appears as a spot 
in a characteristic position (first dimension is ~90 kD, second dimension is ~45 
kD) below the diagonal  that contains  the bulk of the nonreducible cell surface 
components.  Among  the  few  other  reducible  proteins,  Lyt-2  as  well  as  the 
transferrin  receptor can be usually identified (7). 
Fig. 8 contains examples of the analyses of CI 96 cells and some of its functional 
variants by this procedure, and Table  1 gives a  synopsis of all results.  All cells 
that possess lectin-dependent cytotoxic activity (CI 96, type I, II, and III variants) 
express  the  T  cell  antigen  receptor,  regardless  of their  specific  P815  killing 
activity. On the contrary, all but one of the noncytotoxic (type IV) variants are 
negative for the T  cell receptor.  In some cases of negative variants a faint spot 
in this region appears (Fig. 8 e), which may or may not represent low amounts of 
T  cell receptor. 
The  T  cell  antigen  receptor  of  CI  96  appears  as  a  short  diagonal  itself, 
suggesting a certain degree of size heterogeneity which we attribute to different 
degrees of glycosylation (Fig. 8 a  and 9 a).  For its direct identification,  immuno- 
precipitation  was performed  using  rabbit  anti-mouse  T  cell  antigen  receptor 
serum. Compared with the negative control, in which normal nonimmune rabbit 
serum was used, the anti-mouse T  cell receptor serum precipitated a single spot 
below the diagonal with an apparent  molecular mass of 45  kD under reducing 
conditions and 84 kD under nonreducing conditions (Fig. 9, b and c). According JANKOVIC  ET  AL.  1469 
FIGURE 8.  Two-dimensionalnonreduced/reducedSDS-PAGEof125I-labeledmembranepro- 
teins of (a)  CI 96; (b)  96MedA, without ConASN; (c) 96  MedC cultured with ConASN; (d) 
2F6; (e) 4H7; (f)  t 38, all cultured with ConASN. The spot corresponding to T  cell antigen 
receptor runs at  ~45  kD in the second dimension. The spot corresonding to Lyt-2 runs at 
~34 kD in the second dimension. 
to these estimates, the spot precipitated by the anti-T cell receptor antiserum 
corresponds to the spot at the same position seen in the total lysate (Fig.  9,a). 
The same type of autoradiograms were obtained in immunoprecipitation exper- 
iments with several other cytotoxic variants, and, as expected, rabbit anti-mouse 
T  cell receptor serum did not precipitate any reducible molecules from noncy- 
totoxic variants (data not shown). 
Culture of IL-2-independent cells in  IL-2  has no detectable influence on T 
cell receptor expression. This was shown for both type II variants and is shown 
for 96E7 in Fig.  10.  The results of this analysis also confirm serological typing 
for Lyt-2; the spot corresponding to Lyt-2 increases in intensity when the cells 
are  cultured  in  IL-2.  Thus,  the  IL-2-inducible,  specific  P815  cytotoxicity is 
accompanied by an increase in  Lyt-2 expression, whereas the expression of T 
cell receptor remains, within the sensitivity of the method, unaltered. 
Table I  summarizes the results of all assays performed. The results strongly 
suggest that  Lyt-2 and the T  cell receptor together are necessary for specific 
recognition of P815  targets by AK cells. Loss of Lyt-2 leads to loss of specific 
recognition. Loss of the T  cell receptor leads to loss of all cytotoxic activity. The 
one exception to this rule is the type IV variant, 96E12, which possesses negligible 
cytotoxicity in  spite  of its expression of Lyt-2 and of the T  cell receptor. We 
conclude  that  these  molecules are  necessary but  not  sufficient for  cytotoxic 
activity of AK cells. 1470  T  CELL  RECEPTOR  AND  LYT-2  ON  AGED  KILLER  CELLS 
TABLE  1 
Expression  of Lyt-2 and of T Cell Antigen Receptor on Cl 96 and Variants Grown in Presence 
and Absence of rlL-2 
IL-2  in  Lysis of: 
Type  of variants  culture  P815  P815/PHA  Lyt-2  T  receptors 
C! 96  +  + 
I:  96 MedA  -  + 
+  + 
II:  96 MedC  -  - 
+  + 
96E7  -  - 
+  + 
1II:  96G12 
+ 
IV:  96E12 
+ 
138 
+ 
125 
+ 
4H7 
+ 
10A4 
+ 
2F6 
+ 
+  +  + 
+  +  + 
+  +  + 
+  Low  + 
+  +  + 
+  Low  + 
+  +  + 
+  Low  + 
+  Low  + 
-  +  + 
-  +  ND 
-  ND  ND 
-  ND  ND 
-  ND  ND 
-  ND  ND 
-  ND  ND 
Discussion 
Although  the  T  cell  antigen  receptor  has  been  identified  and  molecularly 
characterized  to some degree  (reviewed in  Reference  14)  it  is far  from  being 
understood how this molecule exerts its function: recognition of antigen and of 
MHC  products  on  the  surfaces  of other  cells  (15).  In  the  present  work  we 
evaluated whether AK T  cells would lend themselves to a study of T  cell receptor 
structure-function relationships, since these cells are particularly well adapted to 
growth  in  culture,  and  their  function  is  stable and  easily analyzed.  However, 
since AK T  cells express a  somatically acquired specificity that differs from the 
specificity of their clonal precursors (4), it was essential to decide whether the T 
cell antigen receptor or some other surface structure is responsible for the newly 
acquired specificity. 
Acquisition of lectin-like receptors leading to polyspecific cytotoxicity has been 
postulated for long term and short term  cultured T  cells (3,  16).  If the T  cell 
antigen receptor were responsible for the new recognition specificity, one would 
have to invoke mechanisms for somatic alteration of its structure and specificity. 
Our results lend strong support to the view that the recognition apparatus of 
AK cells closely resembles that of bona fide cytotoxic T  cells. The expression of 
T  cell antigen-receptor  molecules on  AK cells is clearly shown.  Moreover,  we JANKOVIC  ET  AL.  1471 
FIGURE 9.  The  T  cell  antigen  receptor  of CI  96  analyzed  by  two-dimensional nonre- 
125  duced/reduced SDS-PAGE of  I-labeled membrane proteins (a) whole cell lysate, (b) immu- 
noprecipitate with rabbit anti-mouse T  cell receptor serum, and (c) immunoprecipitate with 
rabbit nonimmune serum.  In addition to precipitating the T  cell receptor, the rabbit anti- 
mouse  T  cell receptor serum,  as well as rabbit nonimmune  serum,  forms  a  background 
precipitate which appears in the diagonal. The photographs of the autoradiographs do not 
bring out the fact that the background precipitates represent only a small proportion (total 
cpm in b, 67,805; total cpm in c, 69,220) of the total counts in the lysate (total cpm in a, 106). 
The horizontal configuration across the position of the T  cell receptor spot in b and c is an 
artifact often seen in our gels. 
found that CI 96 and three out of three cytotoxic variants are receptor + and that 
five out  of six  noncytotoxic  variants are receptor-.  Formally, it is possible that 
other molecules, which are obligatorily coexpressed with the T  cell receptor, are 
responsible for P815 recognition by AK cells. The  T  cell antigen receptor is part 
of a  macromolecular  complex that besides diverse o~ and/3 subunits, includes the 
invariant  polypeptides  of  the  T3  antigen.  It  is  unlikely,  though,  that  T3  is 
responsible for the specificity of AK cells because in this case one should expect 1472  T  CELL  RECEPTOR  AND  LYT-2  ON  AGED  KILLER  CELLS 
FIGURE 10.  Two-dimensional nonreduced/reduced SDS-PAGE of ~eSl-labeled membrane 
proteins of Type 11 variant 96E7, cultured in the absence (a) and in the presence (b) of 15% 
ConASN. The  spot  corresponding to  the  T  cell  receptor runs  at  ~45  kD  in  the  second 
dimension. The spot corresponding to Lyt-2 runs at -34 kD in the second dimension and is 
seen only in b. 
that all  T3 ÷ cytotoxic cells lyse P815  targets. The loss  of the T3  molecule, as 
well as the loss of any of the a  or/3 subunits, however, may be the explanation 
for the absence of the complete T  cell antigen receptor complex from the surface 
of noncytotoxic variants. Alternatively, on the basis of our data it is possible that 
the T  cell receptor is required only for the cytotoxicity of AK cells but not for 
their target recognitions. In this case, Lyt-2 would be the prime candidate for 
target  recognition,  which  is  again  unlikely because  all  Lyt-2  +  cytotoxic cells 
should then  lyse P815  target cells. Thus we conclude that  the T  cell antigen 
receptor of AK cells is involved in their target cell recognition. 
From this it follows that long-term cytotoxic T  cell clones may change their 
receptors from one specificity to another during tissue culture. This is a further 
example  of somatic  changes  in  T  cell  receptor  specificity and  complements 
previous observations from our laboratory on changes in restriction crossreactiv- 
ity of TNP-specific CTL clones (17), observations by Augustin and Sim (18) on 
specificity changes in  MHC  class  II-reactive hybridomas, and observations by 
Reimann and Miller (19) on specificity changes of CTL clones in limiting dilution 
cultures. Considering the apparent lack of somatic hypermutation in both T  cell 
antigen receptor genes, the molecular mechanism that leads to such specificity 
changes needs to be determined. It is interesting in this context that a specific 
V/3  gene  with  an  unusual  degree  of homology  with  a  human  leukemic  V~ 
sequence (20) is expressed in more than one independently arisen murine AK 
line  (21),  including  C1  96  (Epplen, J.  T.,  personal  communication).  In  vivo 
systems need to be established to investigate the intriguing possibility that similar JANKOVI~ ET AL.  1473 
intraclonal specificity changes occur during T  cell development and represent 
mechanisms for the somatic diversification of the T  cell repertoire. 
Our data extend previous models of cytotoxicity by showing that the T  cell 
receptor, in addition to its recognition function, is necessary for the activation 
of the cytotoxic machinery. Cells lacking the T cell receptor are also noncytotoxic 
in a  iectin-facilitated assay.  So far,  it has been unclear whether or not lectin- 
dependent cytotoxicity is antigen receptor-dependent (22, 23). For AK cells it 
seems clear  that  activation  of the  cytotoxic machinery occurs via  the  T  cell 
antigen receptor. 
Recently, evidence that the T  cell antigen receptor is a lectin-binding molecule 
has been obtained by several laboratories (24, 25). Inhibition experiments have 
suggested  that  the  target  for  PHA-binding on  human  T  cells is  not  the  T3 
antigen,  but  rather the antigen-specific part  of the T  cell receptor (26).  We 
suggest that the role for the lectin in AK cytotoxicity may be the stabilization of 
a low-affinity receptor antigen interaction. Since the lectin-facilitated AK cyto- 
toxicity is largely specific for P815,  whereas that of bona fide CTL applies to 
many different target cells, AK cells may differ somewhat from bona fide CTL. 
It remains to be studied, by experiments similar to those described here, whether 
the  T  cell  receptor  of bona  fide  CTL  is  also  necessary for  lectin-facilitated 
cytotoxicity. 
The role of Lyt-2 in specific target recognition of AK cells seems to be similar 
to  the  role  of the  lectin  in  lectin  facilitated  lysis.  As  suggested  by  previous 
experiments (27, 28), Lyt-2 participates in target recognition of CTL by enhanc- 
ing  the  affinity of the  interaction  of the  T  cell  receptor  with  its  antigenic 
structure. Accordingly, specific cytotoxicity of AK cells for P815 needs both Lyt- 
2 and the T  cell receptor. This observation is in full agreement with the model 
proposed by McDonald et al. (29) for the function of Lyt-2 in the recognition of 
low-affinity cytotoxic T  lymphocytes. 
In addition to the role of the T  cell receptor and of Lyt-2 in AK killing, we 
find the inducibility by IL-2 of specific cytotoxicity in type II variants especially 
interesting. This inducibility correlates with an increase in the expression of Lyt- 
2,  and  leads  to  the  conclusion  that  Lyt-2  is  essential  for  specific  target  cell 
recognition. IL-2  has recently been shown to  induce specific cytotoxicity in a 
cytotoxic T  cell hybridoma whose growth was independent of IL-2 (30). More- 
over, IL-2 was shown to induce its own receptor on helper T  cell lines (31, 32). 
In none of these reports was evidence obtained that Lyt-2 (or L3T4) was subject 
to regulation by IL-2. Whether or not the present observation reflects a physio- 
logical effect of IL-2 or is unique to the AK system needs to be established. 
The  fact that  specificity variants of AK  type are generated frequently in  a 
number of CTL clones of independent specificity suggests to us that the expres- 
sion of AK activity is intimately connected with an unknown selective advantage 
in tissue culture, either through recognition of an unknown antigen in culture 
or through concomitant activation of a growth promoting gene. Therefore, the 
switch to AK activity may not represent an important event in vivo. However, 
irrespective of how this activity arises, our data show that the lytic activity of AK 
cells uses a classical recognition mechanism, and we therefore suggest that these 
cells can be readily used as a  model for studying the iytic process of bona fide 1474  T  CELL RECEPTOR AND  LYT-2 ON  AGED KILLER CELLS 
CTL.  Moreover,  AK  cells are  interesting  because they can  give  rise  to  IL-2- 
independent  T  cell  lines  with  complete  or  partial  maintenance  of cytotoxic 
function. Such IL-2-independent variants may represent preleukemic cells. Fully 
tumorigenic variants may arise from AK cells that lose cytotoxic function (Simon 
et al.,  manuscript  submitted for publication) or remain  active as cytotoxic cells 
(unpublished observation). Taken together,  we feel that AK cells may be useful 
tools, not only for the study of recognition and cytotoxic effector function of T 
lymphocytes, but also for general questions in cell biology such as induction  of 
function and growth control. 
Summary 
Aged killer (AK) T  cells are antigen-independent,  IL-2-requiring  variants of 
antigen-dependent  CTL  clones that  have  lost their  original  antigen  specificity 
and  have acquired,  instead,  specific cytotoxicity for  P815  target  cells.  In  this 
report  we  study  whether  AK  cells  use  a  similar  or  a  different  target  cell 
recognition system than that of bona fide CTL. To this end, we selected from a 
cloned  AK  line  variants  that  are  partially  or  completely  deficient  in  specific 
target recognition and/or in cytotoxic function, and analyzed these variants for 
expression of the T  cell antigen  receptor and of Lyt-2. Variants  were selected 
from  the  prototype  AK  line  (C1  96)  with  specific,  as  well as  lectin-facilitated, 
cytotoxicity for  P815  tumor  cells.  Variants  could be grouped  into  four types 
with increasing degrees of functional deficiency, which correlated with loss of T 
cell receptor and/or loss of Lyt-2. In short, loss of Lyt-2 was reflected in loss of 
specific target recognition, and loss of the T  cell antigen receptor was reflected 
in loss of all cytotoxic activity. We conclude from these results that (a) both Lyt- 
2 and the T  cell antigen receptor are required for specific target cell recognition 
and (b) the T  cell antigen receptor is, in addition, required for cytotoxic function. 
Moreover, since AK cells express a  somatically acquired  specificity that  differs 
from that of their clonal precursors, it appears that cytotoxic T  cells may change 
their antigen receptor from one specificity to another during tissue culture. 
We thank Ms. Ingrid Falk for expert technical help and Ms. Nele Leibrock for preparation 
of the manuscript. 
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